Tvardi Therapeutics, Inc. (TVRD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.68M | -4.26M | -8.87M | -4.69M | -4.04M | -13.98M | -12.44M | -30.45M | -5.75M | -19.64M |
| Operating CF Margin % | - | - | - | -182.64% | - | - | - | -1426.37% | -191.38% | -403.72% |
| Operating CF Growth % | -40.61% | 69.56% | 28.72% | 84.59% | 29.67% | 28.82% | - | - | - | - |
| Net Income | -7.28M | -5.53M | -506K | -4.91M | -7.68M | -12.48M | -20.02M | -30.7M | -4.35M | -28.03M |
| Depreciation & Amortization | 24K | 24K | 47K | 24K | 24K | 73K | 77K | 42K | 24K | 521K |
| Stock-Based Compensation | 353K | 339K | -719K | 1.43M | 0 | 0 | 0 | 3.35M | 85K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -15K | -7K | -10.13M | 94K | 5.43M | 8.98M | 5.36M | 1.74M | 13K | 3.23M |
| Working Capital Changes | 1.23M | 914K | 2.44M | -1.31M | -1.79M | -10.56M | 2.14M | -4.88M | -1.52M | 4.63M |
| Change in Receivables | 0 | 0 | 0 | -822K | -627K | 451K | 1.1M | 1.1M | 0 | 5.51M |
| Change in Inventory | 0 | 0 | 0 | 0 | -729K | -1K | -392K | 80K | 0 | 154K |
| Change in Payables | 0 | 0 | 2.9M | 0 | -2.29M | -8.05M | -951K | -10.15M | 0 | -2.9M |
| Cash from Investing | 5M | 5.35M | -20.43M | -10.88M | 5M | 2.5M | 15.29M | 25.95M | -30.2M | 23.16M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -210K | -836K | -2.05M | -323K |
| CapEx % of Revenue | - | - | - | - | - | - | - | 39.16% | 68.31% | 6.64% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -32.21M | 0 | 0 | 0 |
| Cash from Financing | 1K | -322K | 22.02M | 1.01M | -1.61M | -694K | -610K | -685K | 36.48M | 1.12M |
| Debt Issued (Net) | 0 | 0 | -1.01M | 1.01M | -1.61M | -694K | -610K | -685K | 36.47M | 0 |
| Equity Issued (Net) | 1K | 107K | 424K | 0 | 0 | 0 | 5K | 0 | 1K | 1.12M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -429K | 22.6M | 0 | 0 | 0 | -5K | 0 | 0 | 0 |
| Net Change in Cash | -684K | 770K | -13.57M | -3.69M | -658K | -10.68M | 2.24M | -5.19M | -5.75M | 4.63M |
| Free Cash Flow | -5.68M | -4.26M | -8.87M | -4.69M | -4.04M | -13.98M | -12.65M | -31.29M | -5.75M | -19.97M |
| FCF Margin % | - | - | - | -182.64% | - | - | - | -1465.53% | -191.38% | -410.36% |
| FCF Growth % | -40.61% | 69.56% | 29.9% | 85% | 29.67% | 29.97% | - | - | - | - |
| FCF per Share | -0.61 | -0.45 | -1.05 | -0.50 | -2.65 | -9.18 | -8.32 | -3.34 | -0.61 | -13.25 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.77x | -2.13x | 0.96x | 0.32x | 2.54x | 1.78x | 0.99x | 0.18x | 0.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |